1Alberts-Grill N, Denning T L, Rezvan A, et al. The role of the vascular dendritic cell network in athemsclerosis[J]. Am J Physiol Cell Physiol, 2013: [ Epub ahead of print].
4Lim H S, Lip G Y. Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology[J]. J Intern Med, 2008, 263(6): 620.
5Daub K, Lindemann S, Langer H, et al. The evil in atherosclemsis: adherent platelets induce foam cell formation [J]. Semin Thromb Hemost, 2007, 33(2) : 173.
7Abilleira S, Bevan S, Markus H S. The role of genetic variants of matrix metalloproteinases in coronary and carotid atheroscle- rosis[J]. J Med Genet, 2006, 43(12): 897.
8Ram M, Sherer Y, Shoenfeld Y. Matrix metalloproteinase-9 and autoimmune diseases[J]. J Clin Immunol, 2006, 26 (4) : 299.
3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：349
4Johnson NP,Gould KL.Clinical evaluation of a new concep t:resting myocardial perfusiou heterogeneity quantified bymarkovian analysis of PET identifies coronarymicrovascular dysfunction and early ath2 eresclerosis in 1,034 subjects.J NuclMed,2005,46(9):1427.
5Stanley C,RobertW,Christopher A.et al.Endothelial dysfunetion in patientswith recentmyocardial infarction and hyperhomo-cystcin2 acmia:effects of vitamin supplementation.Clinical Science,2005,108(1):65.
68Antoniades C,Tousonlis D,Vasiliadou C,et al.Genetic polymor2 phism on endothelial nitric oxide synthase affects endothelial acti2 ration and inflammatory response during the acute phase ofmyocar2 dial infarction.J Am Coll Cardiol,2005,46(6):1101.
79Nathan C,Xie QW.Nitric oxide synthase:roles,tolls and controls[J].Cell,1994,78:915-918.
810Casino PR,Krescence MK,Quyyumi AA,et al.The role of nitric oxide in endothelium-dependent vasodilation of hyperohol-esterolemic patients[J].Circulation,1993,88:2541-2547.
911Landmesser US,piekermann S,Dikalov S,et al.Vascular oxi-dative stress and endothelial dysfunction in patients with chronic heart failure:role of xanthine-oxidase and extracellular superoxide dismutase[J].Circulation,2002,106:3073-3078.
1013Schafer A,Fraccarollo D,Vogt C,et al.Improved endothelial function and reduced platelet activation by chronic HMG-CoA reduelase inhibition with rosuvastatin in rats with streptozotocin-inducod diabetes mellitus[J].Biochem Pharmacol,2007,73:1367-1375.
4Liu Y, Yan F, Liu Y, et al. Aqueous extract of rhubarb stabilizes vulnerable alherosclerotic plaques due to depression of inflammation and lipid accumulation [ J]. Phytother Res, 2008, 22 (7 ) : 935 -942.
6Liu Y,Yan F,Liu Y,et al.Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflamma- tion and lipid accumulation[J].Phytother Res, 2008,22(7) : 935-942.
7Fichtlscherer S, Schmidt-Lucke C, Bojunga S, et al. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD:clinical evidence for pleiotropic functions of statin therapy [J].Eur Heart J,2006,27 (10) : 1182-1190.
8Neda R, Di Monaco A, Careri G, el al.Atorvastatin improves en- dothelial function independently of metabolic and inflammatory sta- tus in patients with a cerebrovascular event [J].Circulation, 2011,124:A13392.
9Szczepanska-Szerej A,Kurzepa J,Wojczal J,et al.Simvastatin- induced prevention of the increase in TNF-a level in the acute phase of ischemic stroke[J].Pharmacol Rep, 2007,59:94-97.
10Ky B,Burke A,Tsimikas S,et al.The influence of pravastain and atorvastain on markers of oxidative stress in hypercholesterolemic humans [J].J Am Coil Cardiol, 2008,51 (17): 1653-1662.
